tumor-induced osteomalacia

Ultragenyx earns 2 rare disease drug approvals—and a validated commercial strategy
Fierce Pharma
Fri, 01/29/21 - 10:00 am
Ultragenyx
FDA
Crysvita
tumor-induced osteomalacia
Kyowa Kirin
Dojolvi
Ultragenyx's Crysvita scores FDA nod in 2nd ultra-rare bone disorder
Fierce Pharma
Thu, 06/18/20 - 08:31 pm
Ultragenyx
Kyowa Kirin
Crysvita
FDA
tumor-induced osteomalacia